• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吗啡后处理对心肌缺血/再灌注损伤的保护作用新靶点:HSP90/Akt和C5a/NF-κB的参与

New targets of morphine postconditioning protection of the myocardium in ischemia/reperfusion injury: Involvement of HSP90/Akt and C5a/NF-κB.

作者信息

Tu Rong-Hui, Wang Dong-Xiao, Zhong Guo-Qiang, Meng Jian-Jun, Wen Hong, Bi Qi, He Yan

机构信息

Department of Geriatric Cardiology, First Affiliated Hospital, Guangxi Medical University, 6 Shuangyong Road, Nanning, 530021, Guangxi, China.

Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention, First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, Guangxi, China.

出版信息

Open Med (Wars). 2021 Oct 18;16(1):1552-1563. doi: 10.1515/med-2021-0340. eCollection 2021.

DOI:10.1515/med-2021-0340
PMID:34722891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8525660/
Abstract

BACKGROUND

Activation of the complement component 5a (C5a) and nuclear factor κB (NF-κB) signaling is an important feature of myocardial ischemia/reperfusion (I/R) injury and recent studies show that morphine postconditioning (MP) attenuates the myocardial injury. However, the mediating cardioprotective mechanisms remain unclear. The present study explores the role and interaction of heat shock protein 90 (HSP90), Akt, C5a, and NF-κB in MP-induced cardioprotection.

METHODS

Male Sprague Dawley rats ( = 160) were randomized into eight groups ( = 20 per group). Rats in the sham group underwent thoracotomy, passing the ligature through the heart but without tying it (150 min), and the other seven groups were subjected to 30 min of anterior descending coronary artery occlusion followed by 2 h of reperfusion and the following treatments: I/R (30 min of ischemia and followed by 2 h of reperfusion); ischemic postconditioning (IPostC, 30 s of ischemia altered with 30 s of reperfusion, repeated for three cycles, and followed by reperfusion for 2 h); MP (0.3 mg/kg morphine administration 10 min before reperfusion); MP combined with the HSP90 inhibitor geldanamycin (GA, 1 mg/kg); MP combined with the Akt inhibitor GSK-690693 (GSK, 20 mg/kg); and MP combined with the C5a inhibitor PMX205 (PMX, 1 mg/kg/day, administration via drinking water for 28 days) and MP combined with the NF-κB inhibitor EVP4593 (QNZ, 1 mg/kg). All inhibitors were administered 10 min before morphine and followed by 2 h reperfusion.

RESULTS

MP significantly reduced the I/R-induced infarct size, the apoptosis, and the release of cardiac troponin I, lactate dehydrogenase (LDH), and creatine kinase-MB. These beneficial effects were accompanied by increased expression of HSP90 and p-Akt, and decreased expression of C5a, NF-κB, tumor necrosis factor α, interleukin-1β, and intercellular cell adhesion molecule 1. However, HSP90 inhibitor GA or Akt inhibitor GSK increased the expression of C5a and NF-κB and prevented MP-induced cardioprotection. Furthermore, GA inhibited the MP-induced upregulation of p-Akt, while GSK did not affect HSP90, indicating that p-Akt acts downstream of HSP90 in MP-induced cardioprotection. In addition, C5a inhibitor PMX enhanced the MP-induced downregulation of NF-κB, while NF-κB inhibitor QNZ had no effect on C5a, indicating that the C5a/NF-κB signaling pathway is involved in MP-induced cardioprotection.

CONCLUSION

HSP90 is critical for MP-mediated cardioprotection possibly by promoting the phosphorylation of Akt and inhibiting the activation of C5a and NF-κB signaling and the subsequent myocardial inflammation, ultimately attenuating the infarct size and cardiomyocyte apoptosis.

摘要

背景

补体成分5a(C5a)和核因子κB(NF-κB)信号通路的激活是心肌缺血/再灌注(I/R)损伤的一个重要特征,最近的研究表明吗啡后处理(MP)可减轻心肌损伤。然而,其介导的心脏保护机制仍不清楚。本研究探讨热休克蛋白90(HSP90)、Akt、C5a和NF-κB在MP诱导的心脏保护中的作用及相互作用。

方法

雄性Sprague Dawley大鼠(n = 160)随机分为八组(每组n = 20)。假手术组大鼠开胸,将结扎线穿过心脏但不结扎(150分钟),其他七组大鼠进行30分钟的冠状动脉前降支结扎,随后再灌注2小时,并给予以下处理:I/R(缺血30分钟,随后再灌注2小时);缺血后处理(IPostC,30秒缺血与30秒再灌注交替,重复三个周期,随后再灌注2小时);MP(再灌注前10分钟给予0.3mg/kg吗啡);MP联合HSP90抑制剂格尔德霉素(GA,1mg/kg);MP联合Akt抑制剂GSK-690693(GSK,20mg/kg);MP联合C5a抑制剂PMX205(PMX,1mg/kg/天,通过饮水给药28天)以及MP联合NF-κB抑制剂EVP4593(QNZ,1mg/kg)。所有抑制剂均在吗啡给药前10分钟给予,随后再灌注2小时。

结果

MP显著减小了I/R诱导的梗死面积、细胞凋亡以及心肌肌钙蛋白I、乳酸脱氢酶(LDH)和肌酸激酶同工酶MB的释放。这些有益作用伴随着HSP90和p-Akt表达的增加,以及C5a、NF-κB、肿瘤坏死因子α、白细胞介素-1β和细胞间黏附分子1表达的降低。然而,HSP90抑制剂GA或Akt抑制剂GSK增加了C5a和NF-κB的表达,并阻止了MP诱导的心脏保护作用。此外,GA抑制了MP诱导的p-Akt上调,而GSK不影响HSP90,表明在MP诱导的心脏保护中p-Akt作用于HSP90的下游。此外,C5a抑制剂PMX增强了MP诱导的NF-κB下调,而NF-κB抑制剂QNZ对C5a没有影响,表明C5a/NF-κB信号通路参与了MP诱导的心脏保护。

结论

HSP90对MP介导的心脏保护至关重要,可能是通过促进Akt的磷酸化并抑制C5a和NF-κB信号通路的激活以及随后的心肌炎症,最终减小梗死面积和心肌细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/bf2bffda65ac/j_med-2021-0340-fig006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/28cbf7d6d4aa/j_med-2021-0340-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/399c990a2c4b/j_med-2021-0340-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/0b90a58c2def/j_med-2021-0340-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/a6937eda097a/j_med-2021-0340-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/3251188f76ff/j_med-2021-0340-fig005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/bf2bffda65ac/j_med-2021-0340-fig006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/28cbf7d6d4aa/j_med-2021-0340-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/399c990a2c4b/j_med-2021-0340-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/0b90a58c2def/j_med-2021-0340-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/a6937eda097a/j_med-2021-0340-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/3251188f76ff/j_med-2021-0340-fig005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b376/8525660/bf2bffda65ac/j_med-2021-0340-fig006.jpg

相似文献

1
New targets of morphine postconditioning protection of the myocardium in ischemia/reperfusion injury: Involvement of HSP90/Akt and C5a/NF-κB.吗啡后处理对心肌缺血/再灌注损伤的保护作用新靶点:HSP90/Akt和C5a/NF-κB的参与
Open Med (Wars). 2021 Oct 18;16(1):1552-1563. doi: 10.1515/med-2021-0340. eCollection 2021.
2
HSP90-Mediates Liraglutide Preconditioning-Induced Cardioprotection by Inhibiting C5a and NF-κB.热休克蛋白90通过抑制C5a和核因子κB介导利拉鲁肽预处理诱导的心脏保护作用。
J Invest Surg. 2022 May;35(5):1012-1020. doi: 10.1080/08941939.2021.1989729. Epub 2021 Oct 20.
3
Effects of heat shock protein 90 on complement activation in myocardial ischemia/reperfusion injury after pioglitazone preconditioning.吡格列酮预处理后心肌缺血/再灌注损伤中热休克蛋白 90 对补体激活的影响。
Adv Clin Exp Med. 2023 Dec;32(12):1401-1412. doi: 10.17219/acem/162578.
4
Exosomal HSP90 induced by remote ischemic preconditioning alleviates myocardial ischemia/reperfusion injury by inhibiting complement activation and inflammation.远程缺血预处理诱导的外体 HSP90 通过抑制补体激活和炎症缓解心肌缺血/再灌注损伤。
BMC Cardiovasc Disord. 2023 Feb 1;23(1):58. doi: 10.1186/s12872-023-03043-y.
5
Role of HSP90 in suppressing TLR4-mediated inflammation in ischemic postconditioning.热休克蛋白90在缺血后适应中抑制Toll样受体4介导的炎症反应中的作用。
Clin Hemorheol Microcirc. 2020;76(1):51-62. doi: 10.3233/CH-200840.
6
Involvement of HSP90 in ischemic postconditioning-induced cardioprotection by inhibition of the complement system, JNK and inflammation.热休克蛋白90通过抑制补体系统、JNK和炎症参与缺血后处理诱导的心脏保护作用。
Acta Cir Bras. 2020 Mar 20;35(1):e202000105. doi: 10.1590/s0102-865020200010000005. eCollection 2020.
7
Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting complement activation and upregulation of miR-499.后适应通过抑制补体激活和上调miR-499减轻心肌缺血再灌注损伤。
Exp Ther Med. 2021 Jul;22(1):684. doi: 10.3892/etm.2021.10116. Epub 2021 Apr 26.
8
Novel functional role of heat shock protein 90 in protein kinase C-mediated ischemic postconditioning.热休克蛋白 90 在蛋白激酶 C 介导的缺血后处理中的新型功能作用。
J Surg Res. 2014 Jun 15;189(2):198-206. doi: 10.1016/j.jss.2014.01.038. Epub 2014 Jan 30.
9
Ischemic postconditioning attenuates the inflammatory response in ischemia/reperfusion myocardium by upregulating miR‑499 and inhibiting TLR2 activation.缺血后处理通过上调 miR-499 抑制 TLR2 激活减轻缺血/再灌注心肌的炎症反应。
Mol Med Rep. 2020 Jul;22(1):209-218. doi: 10.3892/mmr.2020.11104. Epub 2020 Apr 30.
10
[Ischemic postconditioning attenuates ischemia/reperfusion injury in isolated hypertrophied rat heart].缺血后处理减轻离体肥大大鼠心脏的缺血/再灌注损伤
Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Aug;34(8):685-9.

引用本文的文献

1
Heat shock protein 90 mediates the protective effects of vericiguat on myocardial ischemia/reperfusion injury by inhibiting toll-like receptor 4 and c-Jun N-terminal kinases.热休克蛋白90通过抑制Toll样受体4和c-Jun氨基末端激酶介导维立西呱对心肌缺血/再灌注损伤的保护作用。
Iran J Basic Med Sci. 2025;28(9):1220-1229. doi: 10.22038/ijbms.2025.84354.18248.
2
Exosomal HSP90 induced by remote ischemic preconditioning alleviates myocardial ischemia/reperfusion injury by inhibiting complement activation and inflammation.远程缺血预处理诱导的外体 HSP90 通过抑制补体激活和炎症缓解心肌缺血/再灌注损伤。
BMC Cardiovasc Disord. 2023 Feb 1;23(1):58. doi: 10.1186/s12872-023-03043-y.
3

本文引用的文献

1
Membrane Attack Complex in Myocardial Ischemia/Reperfusion Injury: A Systematic Review for Post Mortem Applications.心肌缺血/再灌注损伤中的膜攻击复合物:用于尸检应用的系统评价
Diagnostics (Basel). 2020 Nov 2;10(11):898. doi: 10.3390/diagnostics10110898.
2
Role of HSP90 in suppressing TLR4-mediated inflammation in ischemic postconditioning.热休克蛋白90在缺血后适应中抑制Toll样受体4介导的炎症反应中的作用。
Clin Hemorheol Microcirc. 2020;76(1):51-62. doi: 10.3233/CH-200840.
3
Involvement of HSP90 in ischemic postconditioning-induced cardioprotection by inhibition of the complement system, JNK and inflammation.
The Mystery of EVP4593: Perspectives of the Quinazoline-Derived Compound in the Treatment of Huntington's Disease and Other Human Pathologies.
EVP4593 的奥秘:喹唑啉衍生化合物在治疗亨廷顿病和其他人类疾病中的作用。
Int J Mol Sci. 2022 Dec 11;23(24):15724. doi: 10.3390/ijms232415724.
4
The Role of HSP90 Inhibitors in the Treatment of Cardiovascular Diseases.HSP90 抑制剂在心血管疾病治疗中的作用。
Cells. 2022 Oct 31;11(21):3444. doi: 10.3390/cells11213444.
热休克蛋白90通过抑制补体系统、JNK和炎症参与缺血后处理诱导的心脏保护作用。
Acta Cir Bras. 2020 Mar 20;35(1):e202000105. doi: 10.1590/s0102-865020200010000005. eCollection 2020.
4
Morphine post-conditioning-induced up-regulation of lncRNA TINCR protects cardiomyocytes from ischemia-reperfusion injury via inhibiting degradation and ubiquitination of FGF1.吗啡后处理诱导长链非编码 RNA TINCR 的上调通过抑制 FGF1 的降解和泛素化来保护心肌细胞免受缺血再灌注损伤。
QJM. 2020 Dec 1;113(12):859-869. doi: 10.1093/qjmed/hcaa088.
5
Overexpression of TGR5 alleviates myocardial ischemia/reperfusion injury via AKT/GSK-3β mediated inflammation and mitochondrial pathway.TGR5 的过表达通过 AKT/GSK-3β 介导的炎症和线粒体途径减轻心肌缺血/再灌注损伤。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20193482.
6
Heat shock proteins and their expression in primary murine cardiac cell populations during ischemia and reperfusion.热休克蛋白及其在缺血和再灌注期间原代鼠心肌细胞群体中的表达。
Mol Cell Biochem. 2020 Jan;464(1-2):21-26. doi: 10.1007/s11010-019-03645-1. Epub 2019 Nov 1.
7
miR-488 mediates negative regulation of the AKT/NF-κB pathway by targeting Rac1 in LPS-induced inflammation.miR-488 通过靶向 Rac1 负调控 LPS 诱导的炎症中的 AKT/NF-κB 通路。
J Cell Physiol. 2020 May;235(5):4766-4777. doi: 10.1002/jcp.29354. Epub 2019 Oct 31.
8
Effect of Chronic Continuous Normobaric Hypoxia on Functional State of Cardiac Mitochondria and Tolerance of Isolated Rat Heart to Ischemia and Reperfusion: Role of µ and delta2 Opioid Receptors.慢性持续常压缺氧对心脏线粒体功能状态及离体大鼠心脏对缺血再灌注耐受性的影响:μ 和 δ2 阿片受体的作用。
Physiol Res. 2019 Dec 30;68(6):909-920. doi: 10.33549/physiolres.933945. Epub 2019 Oct 25.
9
Hyperglycemia-Induced Oxidative Stress Abrogates Remifentanil Preconditioning-Mediated Cardioprotection in Diabetic Rats by Impairing Caveolin-3-Modulated PI3K/Akt and JAK2/STAT3 Signaling.高血糖诱导的氧化应激通过损害窖蛋白 3 调节的 PI3K/Akt 和 JAK2/STAT3 信号通路来破坏瑞芬太尼预处理介导的糖尿病大鼠的心肌保护作用。
Oxid Med Cell Longev. 2019 Sep 5;2019:9836302. doi: 10.1155/2019/9836302. eCollection 2019.
10
Hydromorphine postconditioning protects isolated rat heart against ischemia-reperfusion injury via activating P13K/Akt/eNOS signaling.水吗啡后处理通过激活 P13K/Akt/eNOS 信号通路保护分离的大鼠心脏免受缺血再灌注损伤。
Cardiovasc Ther. 2018 Dec;36(6):e12481. doi: 10.1111/1755-5922.12481.